Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification - PubMed (original) (raw)
Affiliations
- PMID: 8036013
Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification
A J Ekstrand et al. Oncogene. 1994 Aug.
Abstract
The most common type of alteration of the epidermal growth factor receptor gene (EGFR) in human glioblastomas results in the synthesis of an aberrant mRNA lacking 801 bases that encode amino acids 6-273 of the receptor's extracellular domain. To study the effects of this mutation on receptor function, we have developed chinese hamster ovary cell transfectants which express the mutant EGF receptor. Comparison of wild-type and mutant receptor properties in this cell host indicates that the truncated receptor does not bind EGF or TGF-alpha and, consequently, DNA synthesis is not stimulated in cultures of mutant transfectants by either grown factor. However, levels of DNA synthesis determined for mutant transfectants in serum-free media are several-fold higher than those determined for corresponding cultures of wild-type transfectants. Western blot analysis with anti-phosphotyrosine antibody indicates that the mutant receptor is constitutively phosphorylated in CHO cells, and the same analysis applied to lysates of glioblastoma biopsies reveals the altered receptor is readily detectable as a phosphotyrosine protein in tumors for which there is evidence of corresponding EGFR gene and transcript alterations. In total, these results indicate that the aberrant EGF receptor synthesized in glioblastomas, and which lacks a portion of the extracellular domain necessary for ligand binding, is an activated tyrosine kinase.
Similar articles
- Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor.
Ekstrand AJ, Liu L, He J, Hamid ML, Longo N, Collins VP, James CD. Ekstrand AJ, et al. Oncogene. 1995 Apr 6;10(7):1455-60. Oncogene. 1995. PMID: 7731699 - Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, Wu J, Elliott R, Habib AA. Ramnarain DB, et al. Cancer Res. 2006 Jan 15;66(2):867-74. doi: 10.1158/0008-5472.CAN-05-2753. Cancer Res. 2006. PMID: 16424019 - Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
Sartor CI, Dziubinski ML, Yu CL, Jove R, Ethier SP. Sartor CI, et al. Cancer Res. 1997 Mar 1;57(5):978-87. Cancer Res. 1997. PMID: 9041204 - [Epidermal growth factor receptor and its mutant properties].
Le F, Zhou TC. Le F, et al. Sheng Li Ke Xue Jin Zhan. 1989 Jul;20(3):206-9. Sheng Li Ke Xue Jin Zhan. 1989. PMID: 2692159 Review. Chinese. No abstract available.
Cited by
- Structural insights into the role and targeting of EGFRvIII.
Bagchi A, Stayrook SE, Xenaki KT, Starbird CA, Doulkeridou S, El Khoulati R, Roovers RC, Schmitz KR, van Bergen En Henegouwen PMP, Ferguson KM. Bagchi A, et al. Structure. 2024 Sep 5;32(9):1367-1380.e6. doi: 10.1016/j.str.2024.05.018. Epub 2024 Jun 21. Structure. 2024. PMID: 38908376 - Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics.
Balana C, Castañer S, Carrato C, Moran T, Lopez-Paradís A, Domenech M, Hernandez A, Puig J. Balana C, et al. Front Neurol. 2022 May 26;13:865171. doi: 10.3389/fneur.2022.865171. eCollection 2022. Front Neurol. 2022. PMID: 35693015 Free PMC article. Review. - Genetically Modified Cellular Therapies for Malignant Gliomas.
Kilian M, Bunse T, Wick W, Platten M, Bunse L. Kilian M, et al. Int J Mol Sci. 2021 Nov 26;22(23):12810. doi: 10.3390/ijms222312810. Int J Mol Sci. 2021. PMID: 34884607 Free PMC article. Review. - New Immunotherapeutic Approaches for Glioblastoma.
Vázquez Cervantes GI, González Esquivel DF, Gómez-Manzo S, Pineda B, Pérez de la Cruz V. Vázquez Cervantes GI, et al. J Immunol Res. 2021 Sep 13;2021:3412906. doi: 10.1155/2021/3412906. eCollection 2021. J Immunol Res. 2021. PMID: 34557553 Free PMC article. Review. - EGFRvIII-CAR-T Cells with PD-1 Knockout Have Improved Anti-Glioma Activity.
Zhu H, You Y, Shen Z, Shi L. Zhu H, et al. Pathol Oncol Res. 2020 Oct;26(4):2135-2141. doi: 10.1007/s12253-019-00759-1. Epub 2020 Jan 27. Pathol Oncol Res. 2020. PMID: 31989402
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous